ATM-depletion in breast cancer cells confers sensitivity to PARP inhibition

BACKGROUND: Mutations in the DNA damage response (DDR) factors, breast cancer 1 (BRCA1) and BRCA2, sensitize tumor cells to poly(ADP-ribose) polymerase (PARP) inhibitors. The ataxia telangiectasia mutated (ATM) kinase is a key DDR protein whose heterozygous germline mutation is a moderate–risk facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilardini Montani, Maria Saveria, Prodosmo, Andrea, Stagni, Venturina, Merli, Dania, Monteonofrio, Laura, Gatti, Veronica, Gentileschi, Maria Pia, Barilà, Daniela, Soddu, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176289/
https://www.ncbi.nlm.nih.gov/pubmed/24252502
http://dx.doi.org/10.1186/1756-9966-32-95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176289/
https://www.ncbi.nlm.nih.gov/pubmed/24252502
http://dx.doi.org/10.1186/1756-9966-32-95

Ejemplares similares